GGrantIndex
← Leaderboards

Dan Mercola

Sidney Kimmel Cancer Center

$17,888,945
Attributed
$19,667,530
Total exposure
6
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.7M · FY200515
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15

Funding mix

By agency

NIH$19,667,530 · 6

By mechanism

U01$16,665,318 · 3
R01$3,002,212 · 3

Top collaborators

Others in their field

Top investigators on “Gene Expression

Research focus

Gene ExpressionNeoplastic CellClinical ResearchProstate NeoplasmsCell LineProgramsSamplingSiteProstateMalignant Neoplasm Of ProstateProspectiveBiopsyBasePrognosticProstate CarcinomaClinically SignificantCell StromaCell TypeCarcinomaGenesProspective StudiesClinical TrialsDiagnosisTissues

Grant awards (26)

The Prostate Cancer Tumor Microenvironment Exhibits Differentially Expressed Gene$138,755
U01 · FY2015 · CA · contact PI
The Prostate Cancer Tumor Microenvironment Exhibits Differentially Expressed Gene$571,567
U01 · FY2014 · CA · contact PI
The Prostate Cancer Tumor Microenvironment Exhibits Differentially Expressed Gene$716,818
U01 · FY2013 · CA · contact PI
The Prostate Cancer Tumor Microenvironment Exhibits Differentially Expressed Gene$781,730
U01 · FY2012 · CA · contact PI
The Prostate Cancer Tumor Microenvironment Exhibits Differentially Expressed Gene$647,645
U01 · FY2011 · CA · contact PI
The Prostate Cancer Tumor Microenvironment Exhibits Differentially Expressed Gene$700,655
U01 · FY2010 · CA · contact PI
Evaluation of Predictive Signatures of Prostate Cancer$1,443,611
U01 · FY2009 · CA · contact PI
Evaluation of Predictive Signatures of Prostate Cancer$1,577,163
U01 · FY2008 · CA · contact PI
Evaluation of Predictive Signatures of Prostate Cancer$1,701,313
U01 · FY2007 · CA · contact PI
Evaluation of Predictive Signatures of Prostate Cancer$1,742,858
U01 · FY2006 · CA · contact PI
Evaluation of Predictive Signatures of Prostate Cancer$1,707,065
U01 · FY2005 · CA
CHARACTERIZATION OF EARLY STAGE PROSTATE CANCER$152,589
U01 · FY2004 · CA
ONCOGENIC ROLE OF JUN KINASE IN HUMAN PROSTATE CANCER$34,638
R01 · FY2004 · CA
CHARACTERIZATION OF EARLY STAGE PROSTATE CANCER$1,264,810
U01 · FY2003 · CA
ONCOGENIC ROLE OF JUN KINASE IN HUMAN PROSTATE CANCER$375,644
R01 · FY2003 · CA
CHARACTERIZATION OF EARLY STAGE PROSTATE CANCER$1,235,070
U01 · FY2002 · CA
ONCOGENIC ROLE OF JUN KINASE IN HUMAN PROSTATE CANCER$375,644
R01 · FY2002 · CA
MECHANISM OF GROWTH REGULATION BY EGR-1$343,240
R01 · FY2002 · CA
CHARACTERIZATION OF EARLY STAGE PROSTATE CANCER$1,194,334
U01 · FY2001 · CA
ONCOGENIC ROLE OF JUN KINASE IN HUMAN PROSTATE CANCER$375,644
R01 · FY2001 · CA
MECHANISM OF GROWTH REGULATION BY EGR-1$318,799
R01 · FY2001 · CA
JUN KINASE AND HUMAN TUMORS$255,831
R01 · FY2001 · CA
CHARACTERIZATION OF EARLY STAGE PROSTATE CANCER$1,089,335
U01 · FY2000 · CA
ONCOGENIC ROLE OF JUN KINASE IN HUMAN PROSTATE CANCER$375,644
R01 · FY2000 · CA
MECHANISM OF GROWTH REGULATION BY EGR-1$309,514
R01 · FY2000 · CA
JUN KINASE AND HUMAN TUMORS$237,614
R01 · FY2000 · CA